Hematology/Oncology

Top Story

Cancer prevalence higher in women with OSA

August 23, 2019
In the Journals

Cancer survivors at higher medium-, long-term risk for cardiovascular disease

August 23, 2019
Survivors of most types of cancers demonstrated increased medium- to long-term risk for at least one cardiovascular disease compared with the general population…
Advanced Practice

Nephrotoxicity among young patients with cancer: Not only an acute problem

HemOnc Today, August 25, 2019
Lisa Triche, DNP, RN, CPNP
Balancing long-term risks and benefits of potentially toxic therapies, while achieving a cure, remains a delicate challenge in cancer treatment. Nephrotoxicity — a…
Pharmacology Consult

Immunotherapy effective for many patients ineligible for registration trials, but caution necessary

HemOnc Today, August 25, 2019
Jai N. Patel, PharmD, BCOP
One of the hot topics at this year’s ASCO Annual Meeting was broadening eligibility criteria to increase clinical trial access and enrollment. Eligibility criteria…
Editorial

America’s new cancer: History repeats itself

HemOnc Today, August 25, 2019
Derek Raghavan, MD, PhD
Long after Doll and Bradford Hill convincingly showed that lung cancer is caused by cigarette smoking, the denizens of the tobacco industry established campaigns of…
More Headlines »
CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Video
Meeting News

VIDEO: Astellas executive highlights key ASCO studies, company pipeline

June 27, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME ABIM MOC

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next